Definitive Contract 75N93023C00028
Award Date 9/15/23
Potential Completion Date 9/14/24
Potential Value $299K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
College Station, TX, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $223,568.00, is for the development of a "Simple, Inexpensive Unit for Removing Cells from Small Amounts of Blood in Resource-Limited Settings." This contract is a Firm Fixed Price...
- This is a federal contract award to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, valued at $299,997.00, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), under the Small Business Innovation Research (SBIR) program. The contract is for the development of a Rapid Point-of-Care HIV Viral Load Test, which aligns with NIAID's mission to conduct and...
- This is a $300,000.00 Firm Fixed Price definitive contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract, titled "CORNAUCOPIA - A METHOD TO DELIVER MULTIPLE BNABS IN THE SAME RNA," is a total small business set-aside with an ultimate completion date of August 14, 2025. Lynntech Inc. has...
- This is a $599,989.00 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Lynntech Inc., a small business technology development company based in College Station, Texas. The contract is for the B-SMART (Broadly Neutralizing Antibodies for SARNA Mediated Antiviral Response Therapy) research project, which is part of the Small Business Innovation Research (SBIR) program. The contract is a Firm...
- This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute, a civilian agency, to Lynntech Inc., a small business technology development company. The $299,984 firm-fixed-price contract is for research and development in the biomedical field, specifically basic research. The contract was set aside for small businesses. Lynntech has extensive experience conducting contracted research and prototype development for various government...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH), awarded a $1,799,353.00 Small Business Innovation Research (SBIR) Program Phase I contract to Redbud Labs, Inc., a for-profit microfluidic chip manufacturer. The contract is a firm fixed price definitive contract to implement extraction compatibility with whole blood and tissue lysates, producing a portable and rapidly installable instrument that meets industry...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Ai Biosciences, Inc., a minority-owned and self-certified small disadvantaged business located in College Station, Texas. The $300,000.00 Firm Fixed Price contract is for the development of a rapid reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay to enable self-monitoring of acute or rebound HIV-1 infection using a finger-prick...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase I contract to Luna Innovations Incorporated, a leading provider of advanced fiber optic sensing and measurement systems. The contract, valued at $224,997, is for the development of "INNOVATIVE ORAL FORMULATIONS FOR ANTI-TB DRUGS." This Firm Fixed Price contract has an ultimate completion date of August 25, 2017. Luna Innovations, a for-profit manufacturer, is...
- Lynntech Inc. has been awarded a $299,864 firm fixed price definitive contract by the National Institutes of Health's National Institute of Allergy and Infectious Diseases to conduct a Small Business Innovation Research Program Phase I feasibility study for the rapid point-of-care diagnosis of Treponema pallidum, the bacterium that causes syphilis. As a total small business set-aside, this Small Business Innovation Research award will support Lynntech's initial research efforts toward developing...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....